Concepedia

Publication | Open Access

Neuroprotective Effects of Angiotensin II Type 1 Receptor Blocker in a Rat Model of Chronic Glaucoma

63

Citations

30

References

2009

Year

Abstract

In the rat chronic glaucoma model, continuous pharmacologic treatment using candesartan results in significant neuroprotection against RGC loss.

References

YearCitations

Page 1